Home / Apremilast / Czechia
CZ ATC L04AA32 · updated 2 Nov 2026
Apremilast shortage in Czechia
Is there an Apremilast shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Apremilast products are reported short in Czechia, the first since 22 Jun 2026. The company estimate for the return is 31 Jan 2027 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Austria. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | APREMILAST TEVA 30MG 30MG TBL FLM 56 | Teva Pharmaceuticals CR, s.r.o., Praha | 22 Jun 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | APREMILAST TEVA 10MG+20MG+30MG 10MG+20MG+30MG TBL FLM 27+POUZDRO | Teva Pharmaceuticals CR, s.r.o., Praha | 13 Jul 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.